1. Home
  2. IPSC vs VTIX Comparison

IPSC vs VTIX Comparison

Compare IPSC & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$6.94

Market Cap

211.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IPSC
VTIX
Founded
2019
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
211.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
VTIX
Price
$2.33
$6.94
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
976.3K
232.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.07
N/A
EPS
0.11
N/A
Revenue
$6,589,000.00
N/A
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.64
N/A
Revenue Growth
194.81
N/A
52 Week Low
$0.34
$4.39
52 Week High
$2.71
$7.15

Technical Indicators

Market Signals
Indicator
IPSC
VTIX
Relative Strength Index (RSI) 62.07 56.88
Support Level $0.49 $4.62
Resistance Level $2.71 N/A
Average True Range (ATR) 0.19 0.80
MACD 0.02 0.18
Stochastic Oscillator 79.33 84.18

Price Performance

Historical Comparison
IPSC
VTIX

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

Share on Social Networks: